Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adelaide A Hebert

Showing results (101-110 of 150) with videos related to

Pageof 15
Sort By:
Pediatric Dermatology|November 20, 2018
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trialsAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
Journal of Drugs in Dermatology : JDD|July 11, 2013
Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxidesLawrence F Eichenfield, Zoe Draelos, Anne W Lucky, et al.
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Treatment of Impetigo and Antimicrobial ResistanceLawrence A Schachner, Charles W Lynde, Leon H Kircik, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic DermatitisLawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, et al.
Journal of the American Academy of Dermatology|July 13, 2010
Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trialRichard G Langley, Amy S Paller, Adelaide A Hebert, et al.
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Pediatric Dermatology|January 10, 2018
Pediatric psoriasis: Evolving perspectivesLawrence F Eichenfield, Amy S Paller, Wynnis L Tom, et al.
Current Medical Research and Opinion|July 10, 2018
Patient impact and economic burden of mild-to-moderate atopic dermatitisAdelaide A Hebert, Georg Stingl, LoAn K Ho, et al.
Dermatology and Therapy|January 8, 2025
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and ChildrenEric L Simpson, Adelaide A Hebert, John Browning, et al.
Pageof 15

Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
Pediatric Dermatology|November 20, 2018
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trialsAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
Journal of Drugs in Dermatology : JDD|July 11, 2013
Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxidesLawrence F Eichenfield, Zoe Draelos, Anne W Lucky, et al.
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Treatment of Impetigo and Antimicrobial ResistanceLawrence A Schachner, Charles W Lynde, Leon H Kircik, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic DermatitisLawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, et al.
Journal of the American Academy of Dermatology|July 13, 2010
Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trialRichard G Langley, Amy S Paller, Adelaide A Hebert, et al.
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Pediatric Dermatology|January 10, 2018
Pediatric psoriasis: Evolving perspectivesLawrence F Eichenfield, Amy S Paller, Wynnis L Tom, et al.
Current Medical Research and Opinion|July 10, 2018
Patient impact and economic burden of mild-to-moderate atopic dermatitisAdelaide A Hebert, Georg Stingl, LoAn K Ho, et al.
Dermatology and Therapy|January 8, 2025
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and ChildrenEric L Simpson, Adelaide A Hebert, John Browning, et al.
Pageof 15